Third Rock Ventures

NinePoint Medical Inc secures $34M in Series B funding round

Corning Inc led the $34 million Series B funding round for Cambridge, Massachusetts-based medical device maker NinePoint Medical Inc, a statement about the funding said.

Read Full Article

Biopharmaceutical firm Igenica Inc nabs additional $14M in Series C extension funding

Igenica Inc, the biopharmaceutical firm dedicated to developing antibodies and antibody-drug conjugates to treat the Big C, obtained $14 million in its Series C extension round.

Read Full Article

Cambridge fat-burning drug maker Zafgen nabs USD45 million in Series E funding

Cambridge-based anti-obesity drug developer Zafgen Inc bagged another USD45 million in a Series E funding round today, bringing its total funding to date to USD114 million.

Read Full Article

Biotech venture capital firms invest USD43 million in Series A funding in Editas Medicine

A consortium of venture capitalists had helped Editas Medicine raised USD43 million in Series A financing to create medicine designed to eradicate gene abnormalities.

Read Full Article

SAGE Therapeutics closes USD 20 million Series B funding round with USD 20 million

Biopharmaceutical firm SAGE Therapeutics scored USD 20 million from ARCH Venture Partners and Third Rock Ventures in its Series B funding round.

Read Full Article

CORRECTED: Alcresta raises US$10 million to help cancer patients

Alcresta announced that it had raised US$10 million to accelerate production and commercialization of its drug that helps cancer patients.

Read Full Article

bluebird bio Secures $60 Million in Oversubscribed Financing

bluebird bio today announced the successful completion of a $60 million Series D financing.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics